1Stern lieb I. Perspectives on wilson 's disese[J].Hepatology,1990.1234-1239. 被引量：1
2Thomas GR,Forbes JR,Roberts EA. The Wilson disease gene:spectrum ofmutations and their consequences[J].Nature Genetics,1995,(06):210-217. 被引量：1
3Nanji MS,Nguyen VT,Kawasoe JH. Haplotype and mutation analysis in Japanese patients with Wilson disease[J].American Journal of Human Genetics,1997,(11):1423-1429. 被引量：1
7Langner C,Denk H. Wilson disease[J].VIRCHOWS ARCHIV-AN INTERNATIONAL Journal OF PATHOLOGY,2004,(08):111-118. 被引量：1
8Walshe JM. Diagnostic significance of reduced serum caeruloplasmin concentration in neurological disease[J].Movement Disorders,2005,(12):1658-1661.doi:10.1002/mds.20628. 被引量：1
9Medici V,Trevisan CP,D'Inca R. Diagnosis and management of Wilson's disease: results of a single center experience.[J].Journal of Clinical Gastroenterology,2006,(10):936-941.doi:10.1097/01.mcg.0000225670.91722.59. 被引量：1
4Loudianos G, Dessi V, Lovicu M, et al. Molecular characterization of Wilson dsease in the Sardinian population-evidence of a founder effect. Hum Mutat, 1999, 14:294-303. 被引量：1
5Cullen LM, Prat L, Cox DW. Genetic variation in the promoter and 5' UTR of the copper transporter, ATP7B, in patients with Wilson disease. Clin Genet, 2003,64:429-432. 被引量：1
6Oh WJ, Kim EK, Park KD, et al. Cloning and characterization of the promoter region of the Wilson disease gene. Bioch Biophys Res Commun, 1999,259:206-211. 被引量：1
7Mizzen CA, Allis CD. Transcription. New insights into an old modification. Science, 2000,289:2290-2291. 被引量：1
8Pedersen AG,Baldi P,Chauvin Y, et al. The biology of eukaryotic promoter prediction. Comput Chem, 1999, 23:191-207. 被引量：1
9Spek CA. Two mutation in the promoter region of the human protein C gene both cause type 1 protein C deficiency by disruption of two HNF-3 binding sites. J Biol Chem, 1995, 270:Z4216-4221. 被引量：1
10Sadhu C, Gedamu L. Regulation of human metallothionein (MT) gene. J Biol Chem, 1988, 263:2679-2684. 被引量：1
